Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes

Insights

Cardiovascular disease, particularly atherosclerotic coronary artery disease, remains a significant global health challenge. This review explores its scope, pathobiology, biomarkers, and the role of inflammation in precision medicine for improved diagnosis and management.

Area of Science:

  • Cardiovascular Medicine
  • Pathobiology
  • Precision Medicine

Background:

  • Cardiovascular disease (CVD) and atherosclerotic coronary artery disease (CAD) represent a major global health and economic burden.
  • Despite historical observations and evolving knowledge of atherosclerosis, significant gaps in understanding persist.
  • Key pathobiological aspects include inflammation, vascular injury response, and impaired homeostasis.

Purpose of the Study:

  • To summarize the current scope and challenges of coronary artery disease.
  • To review emerging pathobiological constructs, clinical phenotypes, and biomarkers.
  • To discuss the 'inflammation hypothesis' and the integration of pathobiology with precision medicine for future advancements.

Main Methods:

  • Literature review and synthesis of existing research on atherosclerosis and coronary artery disease.
  • Analysis of current understanding of disease pathobiology, including inflammation and vascular injury.
  • Examination of clinical trials, biomarkers, and the application of precision medicine.

Main Results:

  • Coronary artery disease presents a substantial and ongoing global health concern.
  • Emerging research highlights inflammation's role in atherosclerosis, alongside vascular injury and homeostasis.
  • Potential biomarkers and clinical trial data are being evaluated to test the 'inflammation hypothesis'.

Conclusions:

  • A comprehensive understanding of coronary artery disease pathobiology is crucial for advancing diagnosis and management.
  • Precision medicine, informed by pathobiology, offers a foundation for personalized strategies in prevention and treatment.
  • Further research integrating pathobiology and clinical data is essential for optimizing patient outcomes.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
448